Although undisputable evidence has clearly demonstrated that the nuclear steps of mRNA processing are mechanistically linked to transcription, a conceptual evolution in gene regulation has come with the realization that transcription might also be functionally connected to more remote processes occurring in the cytoplasm, such as mRNA decay 1,2 . Cytoplasmic mRNA decay is initiated by deadenylation, a rate-limiting event during which the poly(A) tail of the transcript is trimmed off by the CCR4-NOT complex, the main deadenylation machinery in eukaryotes 3 . The degradation of specific mRNAs, a key process in the regulation of eukaryotic gene expression, is achieved through the recruitment of the CCR4-NOT complex by sequence-specific RNA-binding proteins (RBPs) or by the microRNA machinery 3,4 . Poly(A)-shortened mRNAs, along with factors involved in the deadenylation, decapping and mRNA-degradation machineries, accumulate in microscopic mRNA-protein complex (mRNP) aggregates called processing bodies (PBs) 5 .
RESULTS

ERG localizes to PBs and promotes cytoplasmic mRNA decay
Initially, we asked whether the subcellular localization of ERG might be compatible with a potential function in cytoplasmic mRNA decay. To answer this question, we examined the localization of endogenous ERG in HeLa cells, which do not express FLI1 or FEV 18 . ERG localized in the nucleus, consistently with its role as a canonical TF, but also localized in the cytoplasm, where it appeared as discrete foci (Fig. 1a) . We hypothesized that these ERG cytoplasmic foci might be PBs. Indeed, we found that these foci exactly colocalized with decapping protein-1 A (DCP1A) and enhancer of mRNA decapping 4 (EDC4, HEDLS or GE-1), two PB markers 19 ( Fig. 1a and Supplementary Fig. 1a) . Similarly to what has been shown for PBs, cycloheximide treatment led to the disappearence of ERG foci (Fig. 1a) . In addition to the colocalization of ERG in PBs, YFP-tagged versions of the two other Erg subfamily members FLI1 and FEV also colocalized with RFP-tagged DCP1A (Supplementary Fig. 1b) . The localization of ERG in PBs prompted us to test whether ERG might associate with mRNA. To discriminate between proteins directly or indirectly interacting with mRNA, we irradiated cells with UV to covalently cross-link direct RNA-protein interactions, or treated the cells with formaldehyde to fix large protein complexes onto mRNA, and then isolated poly(A)+ mRNPs through an oligo(dT) purification approach 20, 21 . The observation that ERG was exclusively retained on the oligo(dT)-bound fraction from formaldehyde-treated cells indicated that ERG is able to associate with mRNP complexes but not to directly bind mRNA (Fig. 1b) . RBM9, a well described RBP 22 , and GAPDH, which has no known mRNP-related function were used as a positive and negative control, respectively.
We next asked whether ERG might also be found in stress granules (SGs), another type of cytoplasmic granule that forms under stress and exchanges mRNPs with PBs 23 . We subjected HeLa cells to oxidative stress (through arsenite treatment), osmotic stress (through sorbitol treatment) or heat-shock stress and visualized SGs and PBs by staining for RasGAP SH3 domain binding protein (G3BP) 24 and DCP1A, respectively. ERG independently colocalized with both DCP1A and G3BP, thus indicating that it belongs to the set of common components shared between PBs and SGs (Fig. 1c) . Notably, ERG also colocalized with T-cell intracellular antigen-1 (TIA1) and TIA1-related protein (TIAR), two additional SG markers 25 ( Supplementary  Fig. 1c) . Finally, ERG knockdown ( Supplementary Fig. 1d ,e) led to a significant reduction in the number of both PBs and SGs (Fig. 1d,e) , thus establishing ERG as a key component of mRNP complexes cycling between PBs and SGs and supporting its role in mRNA degradation.
On the basis of these observations, we tested the function of ERG in mRNA decay by using a previously described tethering assay 26 . This procedure uses a Renilla luciferase reporter mRNA carrying eight repeats of the binding sequence for the bacteriophage MS2 coat protein (MS2-CP) in its 3′ untranslated region (denoted R-Luc-8MS2), thus allowing specific recruitment of any protein of interest fused to the MS2-CP peptide. We transfected FLAG-tagged constructs encoding either MS2-CP alone or MS2-CP fused with ERG (ERG-MS2-CP) together with the R-Luc-8MS2 reporter or with a control reporter lacking the MS2 binding sites (denoted R-Luc-0MS2). For standardization, the R-Luc-8MS2 and R-Luc-0MS2 constructs expressed firefly luciferase (F-Luc) and Renilla luciferase from the same bidirectional promoter. Recruitment of ERG to the R-Luc transcript specifically reduced the expression of the R-Luc protein in two cancerous cell lines (HeLa and U2OS) and one noncancerous cell line (MRC5). Quantitative mRNA analysis revealed that ERG inhibited R-Luc activity predominantly by reducing the abundance of the tethered R-Luc-8MS2 transcript (Supplementary Fig. 1f) . We next assessed the decay rates of the R-Luc-8MS2 and R-Luc-0MS2 mRNAs in HeLa cells by RT-qPCR under conditions of transcriptional blockage by actinomycin D (ActD). Compared with MS2-CP expression, the expression of ERG-MS2-CP decreased the stability of the R-Luc-8MS2 reporter mRNA but had no effect on the untethered R-Luc-0MS2 mRNA (Fig. 1f) . The ability of ERG to promote mRNA degradation appeared to be independent of its transcriptional activity, because a transcriptionally defective mutant of ERG (W334R 27 Fig. 1g,h) . Finally, ERGmediated mRNA degradation relied on the presence of intact PBs within the cell, because preventing their formation with a short interfering RNA (siRNA) against the key PB component GW182 (ref. 28) significantly reduced degradation of the R-Luc-8MS2 mRNA by ERG ( Fig. 1g and Supplementary Fig. 1i,j) . Altogether, these analyses demonstrated that ERG promotes mRNA degradation when it is recruited to specific transcripts.
ERG promotes mRNA decay through recruitment of CCR4-NOT
To dissect the molecular mechanisms underlying our findings, we performed high-throughput yeast-two hybrid (HT-Y2H) screens. Using a stringent experimental framework described previously, we tested the full-length versions and the isolated functional domains of the three Erg members (Fig. 2a) 30 . Interestingly, in the context of TF-mediated mRNA decay, CNOT2 can associate with chromatin in the nucleus and with PBs in the cytoplasm 30, 31 . To validate these findings, we performed coimmunoprecipitations between FLAG-tagged Erg members and Myc-CNOT2 and found that CNOT2 coimmunoprecipitated efficiently with ERG and FLI1 but poorly with FEV, which lacks an ATAD (Fig. 2a) . When testing the ability of ERG deletion mutants to associate with CNOT2, we observed comparable amounts of CNOT2 copurifying with the full-length ERG protein or with a mutant lacking the central ETS domain, thus indicating that this DNA-binding domain is dispensable for CNOT2 interaction (Fig. 2b) . The mutant lacking the carboxy-terminal transcriptional activation domain (CTAD) still interacted with CNOT2, although this interaction was impaired. In contrast, the absence of the amino-terminal transcriptional activation domain (ATAD) rendered ERG unable to copurify with CNOT2, thus confirming the importance of this domain in the ERG-CNOT2 interaction. Using CNOT2-deletion mutants we found that removal of the Not1 anchor region (NAR, amino acids 350-408) of CNOT2 greatly impaired but did not abolish interaction with ERG 32 (Supplementary Fig. 2a) . We also found that treatment of cell lysates with RNase A dramatically reduced interaction between ERG and CNOT2, thus indicating that formation of a stable ERG-CNOT2 complex relies on RNA and suggesting that both proteins are part of the same mRNPs (Fig. 2c) . Consistently with this idea, endogenous ERG colocalized with CNOT2 in both PBs (Fig. 2d) and SGs (Supplementary Fig. 2b) .
ERG also interacted with CNOT3, a direct partner of CNOT2 in CCR4-NOT 32 (Supplementary Fig. 2c ). Together, CNOT2 and CNOT3 form the NOT module, which is thought to mediate the recruitment of the deadenylase subunits of the CCR4-NOT complex to mRNAs targeted for degradation 3, 33 . Indeed, ERG also coimmunoprecipitated with both deadenylase subunits CNOT6 (CCR4) and CNOT7 (CAF1), a result consistent with a function of ERG in mRNA decay (Supplementary Fig. 2c ). Importantly, we also confirmed interactions between ERG and components of the NOT and deadenylase modules of CCR4-NOT on endogenous proteins (Fig. 2e) .
On the basis of these observations, we speculated that ERG-mediated mRNA decay would rely directly on CNOT2. In agreement with this npg a r t i c l e s possibility, we observed that tethering of the ∆ATAD ERG mutant, which lacks the ability to interact with CNOT2 ( Fig. 2b) , had no effect on the stability of the R-Luc-8MS2 reporter mRNA ( Fig. 2f and Supplementary Fig. 2d ). In addition, knockdown of CNOT2 prevented ERG-mediated degradation of the R-Luc-8MS2 reporter mRNA ( Fig. 2g and Supplementary Fig. 2e ,f) without affecting basal degradation of R-Luc-8MS2 (i.e., in the absence of ERG-MS2-CP tethering). Altogether, these results provide strong evidence that ERG triggers the degradation of bound mRNAs through CNOT2 and recruitment of the CCR4-NOT deadenylation complex.
ERG is recruited to mRNA via its interaction with RBPs
Next, we addressed the critical question of how ERG might be recruited to mRNA. Strikingly, the set of ERG interactors identified in our Y2H screen also included RNA-binding Fox-1 (RBFOX1 or A2BP1) and RNA-binding protein with multiple splicing (RBPMS or Hermes), two RBPs with canonical RNA-recognition motifs 34, 35 (Supplementary Table 1 ). Whereas RBFOX proteins are wellcharacterized splicing factors, the role of RBPMS in mRNA processing remains unclear 36, 37 . From these findings, we hypothesized that ERG might be recruited to specific mRNAs through its interaction with RBPs including RBPMS. Coimmunoprecipitation experiments with ectopically expressed proteins revealed that Erg family members share the ability to associate with RBPMS, thus supporting our model (Fig. 3a) . Importantly, we also confirmed the existence of a physiological ERG-RBPMS interaction by coimmunoprecipitation of endogenous proteins from HeLa cell extracts (Supplementary Fig. 3a) . By using ERG-deletion mutants, we showed that the CTAD is critical for interaction with RBPMS (Supplementary Fig. 3b ). The observations that the ERG-RBPMS interaction did not rely on the presence of RNA (Supplementary Fig. 3c ) and that an RBPMS mutant lacking the RNA-recognition motif still interacted with ERG ( Supplementary Fig. 3d ) suggested that binding to mRNA and association with ERG involve separate domains of RBPMS and are thus compatible with a model in which RBPMS recruits ERG to mRNAs. To test this possibility, we performed indirect RNA immunoprecipitation (RIP) experiments in the context of the tethering assay. We immunoprecipitated FLAG-tagged ERG from cells expressing the R-Luc-8MS2 transcript and tested copurified RNAs for the presence of R-Luc-8MS2 mRNA by RT-qPCR. We detected association between FLAG-ERG and the reporter mRNA only after coexpression of a hemagglutinin (HA)-tagged RBPMS construct fused to the MS2-CP binding module (HA-RBPMS-MS2-CP), thus demonstrating that tethering of RBPMS onto target mRNA promoted co-recruitment of ERG (Fig. 3b) . Consistently with the idea that endogenous RBPMS and ERG might be part of the same mRNP complexes, both proteins colocalized in PBs (white arrows in Fig. 3c) . The observation that some PBs contained ERG but not RBPMS (red arrows in Fig. 3c ) suggested that ERG might be recruited to mRNPs via RBPMS-independent mechanisms, most probably through interaction with other RBPs.
To support the idea that RBPMS might acquire the ability to recruit CNOT2 via its association with ERG, we assessed RBPMS-CNOT2 interaction in HEK-293 cells, which do not express detectable levels of endogenous ERG 18 . Myc-CNOT2 coimmunoprecipitated only with HA-RBPMS from cells ectopically expressing FLAG-ERG, thus indicating that the presence of ERG promoted association between RBPMS and CNOT2 (Fig. 3d) . To formally demonstrate that ERG, RBPMS and CNOT2 can coexist within the same complex, we coexpressed FLAG-ERG, HA-RBPMS and Myc-CNOT2 in HEK-293 cells and immunoprecipitated ERG-associated complexes with anti-FLAG antibodies. After elution with a triple-FLAG (3×FLAG) peptide, we immunoprecipitated HA-RBPMS from the FLAG eluate and examined the presence of Myc-CNOT2 by western blotting. We specifically detected CNOT2 in the ERG-RBPMS immunoprecipitate, demonstrating that the three proteins coexist within the same complex Fig. 3e) . Consistently with this idea, we also found that endogenous RBPMS coimmunoprecipitated with CNOT2 and its partner CNOT3 (Supplementary Fig. 3e ) and observed colocalization of ERG, RBPMS and CNOT2 in cytoplasmic granules of HeLa cells ( Supplementary  Fig. 3f , white arrows). Again, some ERG granules were negative for RBPMS, thus further suggesting that ERG might partner with other RBPs (Supplementary Fig. 3f, red arrows) . Similarly, ERG and RBPMS also colocalized with the CNOT6 deadenylase subunit of CCR4-NOT. Altogether, our data provide compelling evidence that ERG relies on its interaction with RBPs such as RBPMS to associate with transcripts, whose degradation it promotes via recruitment of CNOT2.
ERG, RBPMS and CNOT2 promote degradation of mitotic mRNAs
To identify cellular mRNAs targeted by ERG-mediated degradation, we analyzed genome-wide mRNA stability in ERG-depleted HeLa cells. We collected samples at 0, 0.5, 1, 2 and 4 h after transcription inhibition by ActD from cells transfected with siRNA against ERG (siERG) or control siRNA (siCTL) and assessed the decrease in the abundance of individual mRNAs over time. With this approach, we identified 196 mRNAs (corresponding to 186 individual genes) whose stability was most significantly increased in the absence of ERG (Fig. 4a, green 36 , we found that these ERG degradation targets were strongly enriched in RBPMSassociated mRNAs, thus supporting a functional role for RBPMS in ERG-mediated decay (Fig. 4b) . However, RBPMS-bound mRNAs were significantly more responsive than nontargets to stabilization after ERG knockdown (Fig. 4c) . These findings further support our model in which ERG is recruited to specific mRNAs by various RBP partners, which include RBPMS. Gene ontology (GO) analysis of ERG decay targets highlighted a significant enrichment in genes involved in cell-cycle regulation, including 22 mRNAs directly linked to mitosis (Supplementary Fig. 4a) . Providing a high degree of confidence in the set of ERG mRNA targets, we verified the stabilization of 19 (85%) of these 22 mitotic mRNAs by RT-qPCR (Fig. 4d , dots above the upper dashed line; details in Supplementary Fig. 4b) . Interestingly, the silencing of CNOT2 and RBPMS increased the stability of 18 (95%) and 11 (60%), respectively, of the 19 verified endogenous ERG mitotic targets, thus providing further support to the idea that CNOT2 and RBPMS are key partners in ERG-mediated decay ( Fig. 4d and Supplementary Fig. 4b,c) .
Because our observations indicated that ERG might specifically target mitosis-related transcripts, we tested the importance of ERG-mediated mRNA decay in normal mitotic progression. Mitotic index analysis on synchronized cells showed that ERG-deficient cells progressed through S phase and entered mitosis with kinetics similar to the kinetics of the control population, but they displayed a severe delay in the completion of mitosis (Fig. 5a) . To refine these observations, we Supplementary Fig. 5b ) or showing mitotic defects (Fig. 6a,b) . Samples are from HeLa cells transfected with siCTL or siERG. Results are shown as means ± s.d. (n = 3 independent experiments with 50-100 mitotic cells counted in each replicate). *P < 0.05; ***P < 0.001; NS, not significant compared to siCTL by two-tailed unpaired Student's t test. (d) RT-qPCR decay analysis of the 19 validated ERG mitotic targets ( Fig. 4d and Supplementary Fig. 4b ). Samples are RNA from HeLa cells transfected with either siCTL or siERG, synchronized in S phase, late G2 phase or mitosis, and treated with ActD for 0, 2 or 4 h. The representation is similar to that in Figure 4d (n = 4, 3 and 3 independent experiments for S, late G2 and mitotic cells, respectively). For clarity, s.d. are not shown but are displayed in Supplementary Figure 5c . Source data for a, c and d are available online. npg a r t i c l e s synchronized cells at the G2-M boundary and analyzed the levels of cyclins A2 and B1, whose sequential degradation during the prometaphase-metaphase and metaphase-anaphase transitions, respectively, are used to monitor progression through mitosis 38 . Both control and ERG-depleted cells proceeded through prometaphase and engaged normally in early metaphase, as indicated by the disappearance of cyclin A2 (Fig. 5b and Supplementary Fig. 5a ). However, degradation of cyclin B1 was significantly retarded in siERG-treated cells, thus indicating that ERG depletion prevented progression through metaphase and mitosis completion. Further supporting this possibility, quantification of cells in the various mitotic phases showed that ERGknockdown cells did not proceed to normal metaphase ( Fig. 5c and Supplementary Fig. 5b) . Interestingly, depletion of CNOT2, which led to the stabilization of most of the mitotic ERG-target mRNAs (Fig. 4d) , had a similar effect on mitotic progression, although this effect was less pronounced (Fig. 5b and Supplementary Fig. 5a ). Unfortunately, RBPMS-depleted cells could not be tested in this assay, because G2-M blockage induced massive cell death in these cells. On the basis of the assumption that bulk mRNA degradation would be turned off during mitosis 39 , we reasoned that the stabilization of mitotic mRNAs observed in ERG-deficient cells might be a consequence rather than a cause of the mitotic delay. To investigate this issue, we examined the decay of validated ERG mitotic targets in S, late G2 and early M phases of the cell cycle ( Fig. 5d and  Supplementary Fig. 5c ). Whereas the absence of ERG had little to no significant effect on the mRNA turnover of its mitotic targets during G2 or M phases, it correlated with significant stabilization of the majority of the transcripts during S phase. These analyses indicated that the stabilizing effect associated with ERG depletion mainly affected mRNA during S phase, and it was thus unlikely that the longer time spent by ERG-depleted cells in mitosis accounted for the increase in mRNA stability.
ERG-mediated decay is critical for normal mitotic completion
To determine how ERG depletion affected mitotic progression, we looked for potential mitotic defects in siERG-treated cells. Compared with control cells, cells lacking ERG often exhibited abnormal maturation and fragmentation of their centrosomes ( Fig. 6a and  Supplementary Fig. 6a ). Loss of ERG was also associated with multipolar spindles and aberrant bipolar spindle structures ( Fig. 6b  and Supplementary Fig. 6b,c) , which correlated with chromosome alignment defects ( Fig. 6b and Supplementary Fig. 6d) . Further strengthening the functional links among ERG, RBPMS and CNOT2, we observed similar mitotic abnormalities in RBPMS-and CNOT2-depleted cells (Supplementary Fig. 6e ).
Mitotic defects induced by ERG depletion are similar to those observed in cells overexpressing the Aurora A (AURKA) and B (AURKB) serine/threonine mitotic kinases 40, 41 . Remarkably, mitotic ERG mRNA targets comprised transcripts encoding both AURKA and AURKB as well as multiple regulators (AUNIP and Borealin (CDCA8)), substrates (CDC25, Hice1 (HAUS8), CENPA, Borealin (CDCA8) and CDCA2) and interaction partners (PSRC1) of the Aurora kinases (Supplementary Fig. 4b ). We thus speculated that the mitotic defects observed in ERG-deficient cells might result from a r t i c l e s impaired degradation and accumulation of Aurora-related mRNAs, thus resulting in overactivation or untimely activation of Aurora signaling. In agreement with this possibility, depletion of ERG with two independent siRNAs reduced the S-phase-associated decay of Aurora-related mRNAs, including AURKA and AURKB ( Fig. 5d and Supplementary Fig. 6f for siERG 1 and siERG 2, respectively).
To refine these observations, we counted single AURKA transcripts in the cytoplasm and nuclei of siCTL-and siERG-transfected cells arrested in S phase, by using single-molecule RNA fluorescence in situ hybridization (RNA smFISH). Compared with control cells, ERG-deficient cells contained significantly more AURKA transcripts in their cytoplasm, thus supporting the idea of ERG being important for the cytoplasmic decay of AURKA mRNA ( Supplementary  Fig. 6g,h ). To strengthen these findings, we tested whether ERG associates with AURKA and AURKB mRNAs. By performing RIP on extracts from inducible HeLa cells expressing FLAG-ERG close to endogenous levels, and subsequent RT-qPCR analysis, we found that ERG immunoprecipitates were significantly enriched in AURKA and AURKB mRNAs (Fig. 6c) . RBPMS and CNOT2 also associated with AURKA and AURKB mRNAs (Fig. 6c) , thus supporting the possibility that these proteins participate in ERG-mediated mRNA decay. Consistently with a defect in ERG-mediated decay during S phase, ERG-deficient cells accumulated higher levels of AURKA and AURKB mRNAs as they progressed through S phase and consequently exhibited more transcripts in G2 and when entering mitosis (Fig. 6d) . The higher levels of AURKA and AURKB mRNAs in ERG-depleted cells translated into increased expression of Aurora kinases ( Fig. 6e and Supplementary  Fig. 6i) . Consequently, cells lacking ERG activated Aurora kinases prematurely and thus entered mitosis with hyperactivated Aurora signaling, as compared with control cells (Fig. 6e and Supplementary Fig. 6j ). Suboptimal concentrations of ZM447439 (0.5 µg/ml), a specific inhibitor of Aurora A and B, significantly reverted the various mitotic defects associated with a lack of ERG, without substantially affecting the control cells (Fig. 6f) . This result demonstrated the causal role of Aurora overactivation in siERG-associated mitotic defects.
Collectively, these results clearly establish a role of ERG in mRNA decay and reveal an important biological context for this new function by showing that ERG-mediated degradation of Aurora-related transcripts is critical to ensure proper progression through metaphase during mitosis (Fig. 7) .
DISCUSSION
In terms of efficiency, robustness, adaptability and precision of the gene-expression response, the advantages of coupling mRNA synthesis to degradation are obvious. However, mostly because of the physical barrier of the nuclear envelope between the two processes, the idea of a possible connection between transcription and decay has long been set aside.
In this work, we provide a substantial body of evidence demonstrating that the transcription factor ERG can achieve control of gene expression by directly affecting cytoplasmic mRNA decay, the endpoint of mRNA lifespan. Although the present demonstration that mammalian TFs can actively participate in the process of cytoplasmic mRNA degradation was highly unexpected, our work comes in the wake of recent genetic and molecular evidence establishing functional coupling between mRNA synthesis and degradation in yeast [42] [43] [44] . In particular, specific promoter sequences in yeast have been shown to influence cytoplasmic mRNA decay, presumably through their associated TFs 12, 13 .
Erg proteins are canonical mammalian TFs that bind to specific recognition elements (Ets-binding sites) in the promoters of their transcriptional targets. Using available ERG chromatin immunoprecipitation (ChIP) data sets 45, 46 , we found that ERG-target mRNAs are statistically enriched in ERG-associated genes (P = 5.43 10 −13 by Pearson's chi-squared test; data not shown). Similarly, mRNAs synthesized from ERG-associated genes were significantly more stabilized than nontargets after ERG knockdown (P = 1.08 10 −9 by KolmogorovSmirnov test; data not shown). These results indicate a strong correlation between the presence of ERG at a specific gene locus and its ability to control the degradation of the corresponding mRNA. In yeast, the emerging model suggests that the TFs may control mRNA fate by coordinating the loading of mRNA-decay regulators, Figure 7 ERG controls decay of Aurora-related mRNA transcripts in the cytoplasm via RBPMS and CNOT2. Model illustrating the new function of ERG in mRNA decay identified in this study. A portion of nuclear ERG might be recruited to the promoters of genes involved in the Aurora pathway. At some stage during or after transcription, ERG is loaded onto the transcripts via interaction of its CTAD with RBPMS and presumably other RNA-binding proteins (RBPs). At an undefined stage, ERG aids in recruiting the CCR4-NOT deadenylation complex, by virtue of its capacity to interact with CNOT2 via its ATAD. The ERG-RBPMS-CNOT2-mRNA complex accumulates in P bodies, where poly(A)-tail shortening and mRNA degradation are carried out. ERG-mediated degradation of Aurorarelated transcripts occurs specifically during S phase and counteracts mRNA synthesis before entry into mitosis. The balance between mRNA synthesis and ERG-dependent decay tightly controls the levels of Aurorarelated transcripts and ensures proper regulation of Aurora signaling activity during mitosis. Pol, polymerase.
a r t i c l e s such as components of deadenylation machineries on the transcribing mRNA (so-called mRNA imprinting 14 ). In this model, the coordinating TF is not incorporated into the mRNP. In contrast, our observations suggest that ERG is indeed an mRNP component and that it actively participates in the degradation of the imprinted mRNA in the cytoplasm (Fig. 7) . It will now be essential to determine whether the ERG molecules that are bound to promoter sequences and control transcriptional events are also the ones that are incorporated into mRNPs and are involved in the regulation of mRNA decay. Our Y2H screening revealed that ERG interacts with at least two RBPs implicated in mRNA decay and splicing. Although we focused our attention on mRNA decay, our results suggest that ERG proteins might achieve control of gene expression by orchestrating multiple processes between transcription and decay. In addition, we have recently found 15 TFs among the RBPMS partners in our proteome-scale human interactome (GO: sequence-specific DNA binding) 47 . Therefore, a wide range of TFs and RBPs may actually collaborate in coupling transcriptional and post-transcriptional processes and machineries through the formation of highly versatile functional platforms. In terms of RNA degradation, targeting of the CCR4-NOT complex to specific mRNAs is known to involve interactions with sequence-specific RBPs 3 . On the basis of our study, we speculate that an additional level of specificity might be achieved through interactions with sequence-specific DNAbinding factors, such as ERG. In this case, transcript-specific targeting of CNOT2 would rely combinatorially on its promoter-specific recruitment by TFs and RBP-dependent loading onto the transcribing mRNA. It is also notable that the coordinated functions of CCR4-NOT in transcription and mRNA decay rely more specifically on its NOT2-NOT3 module, which interacts with ERG 11 .
The levels and activities of Aurora kinases are precisely modulated throughout the cell cycle via a complex network of regulatory mechanisms that involves control of mRNA synthesis and translation rates, post-translational modifications, association with specific cofactors and protein degradation 48 . Surprisingly, the contribution of mRNA decay has been largely overlooked in studies of mitosis regulation 13, 49, 50 . Here, we demonstrate that mRNA degradation of Aurorarelated transcripts prominently contributes to mitotic progression in higher eukaryotes. Our findings provide a new model of mitosis regulation in which mRNA decay participates in the orchestration of sequential mitotic events by ensuring the rapid and robust inactivation of critical mitotic effectors.
Overall, our study defines a new and unexpected function of the transcription factor ERG in cytoplasmic mRNA decay. The possibility that our findings might be extended to a wide range of transcription factors not only affects the current model of eukaryotic gene regulation but also provides a mechanistic model for how gene-specific and condition-specific coupling between mRNA synthesis and degradation might be achieved 51, 52 .
METHODS
Methods and any associated references are available in the online version of the paper. 
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We thank the Vidal laboratory at the Center for Cancer Systems Biology at the Dana-Farber Cancer Institute (CCSB, DFCI) for supplying reagents, advice and technical support for the HT-Y2H screen. We thank the Tuschl laboratory (Howard Hughes Medical Institute, Rockefeller University) for sharing reagents. We are grateful to E. Izaurralde (European Molecular Biology Laboratory) for kindly providing HA-tagged CNOT2, CNOT3, CNOT6 and CNOT. We would like to thank the laboratories of the Molecular Biology in Diseases Unit (GIGA-R, ULg) for helpful discussions and C. Vindry from the Kruys laboratory for technical assistance. We thank the GIGA interactomics, imaging and flow cytometry and genotranscriptomics platforms for their technical support. This work was supported by grants from the University of Liège, the Fonds Léon Oligo(dT) pulldowns. The oligo(dT) pulldown procedure was derived from refs. 20,21. HeLa cells were washed twice in cold PBS and either UV cross-linked (0.4 J/cm 2 of 365-nm UV light with a Stratalinker 2400) or paraformaldehyde fixed (scraped cells were resuspended in PBS with 0.1% paraformaldehyde and rotated for 10 min at room temperature, 10 ml per 15-cm dish). PAF fixation was quenched by glycine (final concentration of 125 mM for 10 min at room temperature, with rotation), and cells were washed two times with cold PBS. UV-cross-linked and PAF-fixed cells were lysed in oligo(dT) lysis buffer (20 mM Tris-HCl, pH 7.5, 500 mM LiCl, 0.5% SDS, 1 mM EDTA, 1 mM DTT, cOmplete Protease Inhibitor (Roche), Halt Phosphatase Inhibitors (Thermo Scientific) and Protector RNase Inhibitor (Roche)), and cell lysates were homogenized by three or four passages through a syringe with a 0.4-mm diameter needle (overhomogenization leads to less viscous lysates but also to mRNP breakage). Homogenized cell lysates were then incubated at 37 °C for 30 min with or without RNase A (200 µg/ml Thermo Scientific) (neither DTT nor RNase protector was added in the RNase-treated samples used as negative controls for oligo(dT) pulldown). 1% of each cell lysate was kept for input, and the rest was incubated with oligo(dT) magnetic beads (New England BioLabs) for 2 h at 4 °C (25 µl of beads per 15-cm culture dish). Pulldowns were washed once with wash buffer I (20 mM Tris-HCl, pH 7.5, 500 mM LiCl, 0.1% SDS, 1 mM EDTA and 1 mM DTT), once with wash buffer II (20 mM Tris-HCl, pH 7.5, 500 mM LiCl, 1 mM EDTA and 1 mM DTT) and once with wash buffer III (20 mM Tris-HCl, pH 7.5, 200 mM LiCl, 1 mM EDTA and 1 mM DTT). Cell lysates and successive washes remained viscous, and thus bead homogenization was sometimes difficult, and bead separation (PureProteome Magnetic Stand, Millipore) took several minutes. Beads and inputs were resuspended in 2× SDS loading buffer, sonicated for 5 min (Diagenode Bioruptor, 30 s on/30 s off, medium amplitude) to reduce viscosity, boiled and analyzed by SDS-PAGE and western blotting.
(BD Biosciences). Mitotic cells were identified as 2n cells positive for phophohistone H3 with CellQuest Pro (BD Biosciences).
Statistical analyses.
Graph values are presented as mean ± s.d., calculated for at least three independent experiments. The significance between means was determined with a two-tailed unpaired Student's t test. Normality was verified on control decay curves with Shapiro-Wilk tests (P < 0.01), and variance equality was verified for each test with an F test. P-value thresholds are depicted as follows: *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant; ND, not determined. Significance in the overlap between ERG mRNA-decay targets and RBPMS PAR-CLIP mRNA targets or ERG ChIP gene targets was determined with Pearson's chi-squared test, considering the global set 15,532 different genes with a negative decay slope in siCTL HeLa cells (described for microarray analysis above). The significance between cumulative fraction curves was calculated with a Kolmogorov-Smirnov test.
